These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27162312)

  • 1. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
    Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
    Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GEOS (Gabitril Epilepsy Observational Study) -- Polish results of the international study of tiagabine in partial epilepsy].
    Niedzielska K
    Neurol Neurochir Pol; 2005; 39(6):459-65. PubMed ID: 16355303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy].
    Kozik A; Krause M
    Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine as add-on therapy may be more effective with valproic acid--open label, multicentre study of patients with focal epilepsy.
    Jedrzejczak J
    Eur J Neurol; 2005 Mar; 12(3):176-80. PubMed ID: 15693805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An open study of tiagabine in partial epilepsy].
    Arroyo S; Salas-Puig J;
    Rev Neurol; 2001 Jun 1-15; 32(11):1041-6. PubMed ID: 11562825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Open study with tiagabine in partial epilepsy].
    Arroyo S
    Rev Neurol; 2000 Oct 16-31; 31(8):728-32. PubMed ID: 11082879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiagabine add-on for drug-resistant partial epilepsy.
    Pereira J; Marson AG; Hutton JL
    Cochrane Database Syst Rev; 2002; (3):CD001908. PubMed ID: 12137637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.
    Uthman BM; Rowan AJ; Ahmann PA; Leppik IE; Schachter SC; Sommerville KW; Shu V
    Arch Neurol; 1998 Jan; 55(1):56-62. PubMed ID: 9443711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
    Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
    Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tiagabine in drug-resistant epilepsy in children: preliminary study].
    Wendorff J; Popielarczyk M; Zubiel M; Sokołowska D
    Neurol Neurochir Pol; 2000; 34 Suppl 1():221-4. PubMed ID: 10768162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
    Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
    Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [symbol: see text] Tiagabine: add-on treatment for partial seizures.
    Drug Ther Bull; 2000 Jun; 38(6):47-8. PubMed ID: 10912300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.
    Richens A; Chadwick DW; Duncan JS; Dam M; Gram L; Mikkelsen M; Morrow J; Mengel H; Shu V; McKelvy JF
    Epilepsy Res; 1995 May; 21(1):37-42. PubMed ID: 7641674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.